IL‐18 is highly expressed in the pulmonary macrophages of COVID‐19 patients [127], while a positive correlation with poor clinical outcomes or side effects has been widely demonstrated [118, 128, 129, 130]. This evidence concerns the gene IL18 and COVID-19.